In conversation with WIRED

Professor Mark Kendall’s inventions have drawn attention from some of the world’s biggest names. Think the World Health Organization, the Bill & Melinda Gates Foundation and F1 Grand Prix winner Mark Webber.

The backing of a proven sporting degree

Mark Webber

WearOptimo is proud to count Mark Webber AO as an investor and strategic partner. The Formula 1 champion and endurance athlete came on board after meeting WearOptimo founder and CEO Professor Mark Kendall through a mutual association with luxury watch brand Rolex.

A critical conversation with Planet Hope

Cardiovascular disease is the biggest killer on the planet, claiming more than 30 million lives annually. It’s a horrifying statistic. One made even more so when you consider that all too often – especially with heart attacks – treatment could be as simple as taking an aspirin. If only the victim had more time to act.

Trials attract national attention

In recognition of the start of human trials for our hydration Microwearable sensor, WearOptimo has been the subject of a special 9 News feature.

No sweat as WearOptimo and Aspen Medical reach another milestone

Pictured (from left to right) - Professor Mark Kendall (Founder and CEO of WearOptimo), Professor Brian Schmidt (Vice-Chancellor of The Australian National University), and Glenn Keys (Aspen Medical Founder and Executive Chairman).

Healthtech innovator WearOptimo and leading healthcare provider Aspen Medical have reached another significant milestone in the commercialisation of ground-breaking microwearable hydration sensors.

Aspen Medical has shown its further confidence in WearOptimo by following up its multi-million-dollar investment with the finalisation of a Strategic Collaboration Agreement and Distribution Framework Agreement.

Clinical trials get the green light

Human trials of a microwearable sensor for the detection of dangerous dehydration levels are set to begin after the latest successful fundraising round for HealthTech firm WearOptimo. The $5 million boost will enable the company to progress its game-changing hydration monitor, through clinical trials at QUT.

Manufacturing project worth $3.9 million

We are very excited to share that WearOptimo has been awarded a $973,000 grant under the Australian Government’s Manufacturing Modernisation Fund (MMF) through the Department of Industry, Science, Energy and Resources.

$30 million manufacturing project

WearOptimo are delighted to announce our partnership with the Queensland Government, The Australian National University (ANU), The Australian National Fabrication Facility (ANFF), and others in a $30 million project. This project will support the production of our world-leading, lifesaving MicrowearableTM technology at a new Queensland facility which will be key in creating hundreds of high-value jobs throughout this decade. This project aligns with the government’s Queensland Biomedical 10-Year Roadmap and Action Plan to make Queensland a globally competitive Asia-Pacific biomedical hub by 2027.

World-leading, lifesaving wearable medical technology will be produced at a new Queensland facility, supported by an up to $30 million project announced today.